Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: minoxidil: tab minoxidil 2.5 mg OD for 9 months
Control Intervention1: minoxidil with finasteride combination: topical minoxidil(5%) with finasteride (0.1%) 1 ml twice daily
Sponsors
Dr Pooja Thakur
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with patterned hairloss 2. Norwood Hamilton grade 3,4,5 3. Patients who have not taken medical treatment for AGA in any form for the last 6 months
Exclusion criteria
Exclusion criteria: 1. Patients with abnormal blood pressure or pulse rate 2. Patients with history or current evidence of associated medical condition (thyroid disorder, uncontrolled hypertension, uncontrolled diabetes mellitus, coronary artery disease, cerebrovascular or cardiovascular disease, unstable liver disease, AIDS, pheochromocytoma, etc.) 3. Patients with history or current evidence of malignancy (within last 5 years) 4. Patients with significant lab abnormalities(AST or ALT greater than 2 folds of normal, ALP greater than 1.5 folds of normal, creatinine greater than 2mg per dl, Serum PSA lever greater than 2ng per ml) 5. Patients with alopecia other than Androgenetic alopecia 6. Patients with scalp disorders like scalp psoriasis or severe seborrheic dermatitis at the area of treatment 7. Current evidence of any serious or unstable preexisting psychiatric disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy and safety of low dose oral minoxidil(2.5mg) and topical minoxidil(5%) fortified with finasteride (0.1%) in treatment of male androgenetic alopeciaTimepoint: At baseline, 3 months, 6 months and 9 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Anuj Sharma
Dr. Rajendra Prasad Goverment Medical College
Outcome results
None listed